AXTI vs NVDA
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
AXTI's deterministic health score is weak, with a Piotroski F-Score of 4/9 indicating borderline financial stability. Despite strong revenue growth of 18.2% and improving earnings trends, the company remains unprofitable with negative margins and ROE, undermining its fundamental strength. Valuation metrics are stretched relative to peers, while insider selling and inconsistent earnings beats suggest caution. However, analyst consensus remains at 'buy' and recent price momentum reflects market optimism about turnaround prospects.
NVDA shows bullish fundamentals based on deterministic rules. Financial strength is strong (F-Score 7/9). Key strengths include strong valuation and growth metrics. Price trades at a 20.7% premium to fair value estimate ($144.55), limiting near-term upside from a valuation perspective.
Compare Another Pair
Related Comparisons
AXTI vs NVDA: Head-to-Head Comparison
This page compares AXT, Inc. (AXTI) and NVIDIA Corporation (NVDA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.